-+ 0.00%
-+ 0.00%
-+ 0.00%

BioLine Rx Q1 Sales $477.000K Beat $343.000K Estimate

Benzinga·05/27/2026 11:02:57
Listen to the news
BioLine Rx (NASDAQ:BLRX) reported quarterly sales of $477.000 thousand which beat the analyst consensus estimate of $343.000 thousand by 39.07 percent. This is a 87.06 percent increase over sales of $255.000 thousand the same period last year.